X4 Pharmaceuticals (XFOR) Payables (2017 - 2026)
X4 Pharmaceuticals (XFOR) reported Payables of $3.93 million for Q2 2026, down 49.0% from $7.71 million a year earlier and down 22.5% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, X4 Pharmaceuticals posted Payables of $5.7 million, down 33.9% from FY2024.
- Payables has a five-year compound annual growth rate of 12.6% (FY2020 to FY2025).
- By year, Payables came in at $8.62 million in FY2024 (-3.6%), $8.95 million in FY2023 (+15.0%), $7.78 million in FY2022 (+81.6%) and $4.28 million in FY2021 (+36.2%).
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q3 2022.
- Year over year, Payables has now declined in each of the last five quarters, with an average decline of 19.4% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q3 2023 (growth of 114.0%); the low point was Q1 2026 (a decline of 54.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.07 million (Q1 2026), $5.7 million (Q4 2025) and $5.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | X4 Pharmaceuticals | 381.56 Mn | -317.13 Mn | 7.19 Mn | 3.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Mn |
| Mar 31, 2026 | 5.07 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 5.05 Mn |
| Jun 30, 2025 | 7.71 Mn |
| Mar 31, 2025 | 11.12 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 8.58 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 8.94 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 5.11 Mn |
| Mar 31, 2023 | 5.99 Mn |
| Dec 31, 2022 | 7.78 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | 3.57 Mn |
| Dec 31, 2021 | 4.28 Mn |
| Sep 30, 2021 | 2.42 Mn |
API Access
X4 Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();